Labor Induction in Obese Pregnancies at Term: Risk Factors and Pregnancy Outcomes
Huwaida Nabilah1,2, Hermanto Tri Joewono1,3, Muhammad Ilham Aldika Akbar1,3
1Department Obstetrics & Gynecology, Faculty of Medicine Universitas Airlangga, Surabaya, Indonesia.
Objectives:
The objectives of this study are to identify risk factors associated with failed labor induction in obese pregnancies at term and evaluate related maternal and neonatal outcomes.
Methods:
This cross-sectional study included obese pregnant women (BMI ≥ 30 kg/m2) who underwent labor induction at 37-41 weeks' gestation in two academic hospitals in Surabaya, Indonesia, during 2023. Participants were classified into successful and failed induction groups. Maternal characteristics, induction-related factors, and pregnancy outcomes were compared. Multivariable logistic regression was used to identify independent risk factors for induction failure.
Results:
A total of 159 women were included, comprising 53 failed and 106 successful inductions. Failed induction was significantly associated with primiparity (adjusted odds ratio [aOR], 3.10; 95% CI, 1.46-6.58), Bishop score < 3 (aOR, 2.02; 95% CI, 1.14-3.55), and higher maternal weight gain during pregnancy (aOR per kg increase, 0.89; 95% CI, 0.84-0.95). Maternal weight gain demonstrated a moderate effect size (standardized mean difference, 0.62). Compared with successful induction, failed induction was associated with higher rates of severe preeclampsia (18.9% vs. 1.9%), cesarean delivery (100% vs. 5.7%), longer hospitalization, and lower 1-min Apgar scores. No significant differences were observed in 5-min Apgar scores, fetal growth restriction, congenital anomalies, or NICU admission.
Conclusions:
In obese pregnancies at term, primiparity, unfavorable cervical status, and excessive gestational weight gain are independently associated with failed labor induction. These findings highlight the importance of optimized patient selection, cervical assessment, and anticipatory counseling to improve maternal and neonatal outcomes.
Related Concept Videos
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Diabetes Mellitus: Type 2 and Gestational
Obesity
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...


